Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Not applicable

Salutare One Referral Software Impact on Multi-Disciplinary Team (MDT) Meetings Effectiveness and Safety

NCT07104955 · tracked via the Priya Life Science UK tracker
Sponsor
Salutare Group Ltd
Phase
Not applicable
Started
2025-07-31
Last updated
2025-08-05

Condition(s) studied

Cancer (Solid Tumors)Sarcoma

Investigational drug(s) / intervention(s)

MDT referral and review software

MDT referral and review software: Use of the multi-disciplinary team (MDT) meeting software to submit, review and discuss referrals

Study summary

Multi-Disciplinary Team (MDT) meetings are crucial for planning patient care in the National Health Service (NHS), but they can be time-consuming and sometimes lack complete patient information. This can lead to delays in treatment decisions, potentially incomplete care plans, or the need to repeatedly discuss the same patient cases.

This study aims to test a new software called Salutare One Referral. One Referral is designed to make these meetings more efficient and effective. We want to see if this software can help healthcare staff prepare MDT referral information more easily and facilitate a more informed MDT discussion, which could lead to better patient care. If successful, this could help improve how MDTs operate across the NHS.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * MDT meeting Panel Members, Coordinators and staff submitting MDT referrals will take part in this study. Exclusion Criteria: * MDT meeting Panel Members, Coordinators and staff submitting MDT referrals who are unwilling or unable to take part in the study.

Primary outcome measure(s)

  • One Referral system safety in facilitating effective MDT meetings — 8 weeks (4 MDT meetings) for complex MDTs or 4 weeks (8 MDT meetings) for high-volume MDTs
    MDT panel participant feedback on safety and operational incidents
  • One Referral system implementation feasibility in facilitating effective MDT meetings — 8 weeks (4 MDT meetings) for complex MDTs or 4 weeks (8 MDT meetings) for high-volume MDTs
    MDT panel participant feedback on effectiveness (non-validated questionnaire)
  • One Referral system acceptability to MDT panel members acceptability in facilitating — 8 weeks (4 MDT meetings) for complex MDTs or 4 weeks (8 MDT meetings) for high-volume MDTs
    MDT panel participant feedback on acceptability (Software Usability Scale 0-100, higher score indicate a better outcome)

Trial sites (1)

FacilityCityRegionStatus
Royal National Orthopaedic Hospital London United Kingdom Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07104955 on ClinicalTrials.gov ↗ ← All trials in the UK